Q1 2020 13F Holders as of 3/31/2020
-
Type / Class
-
Equity / Common Stock, $0.001 par value per share
-
Shares outstanding
-
10.9M
-
Number of holders
-
183
-
Total 13F shares, excl. options
-
12.4M
-
Shares change
-
-841K
-
Total reported value, excl. options
-
$774M
-
Value change
-
-$72.2M
-
Put/Call ratio
-
4.16
-
Number of buys
-
85
-
Number of sells
-
-113
-
Price
-
$62.50
Significant Holders of MEDIFAST INC - Common Stock, $0.001 par value per share (MED) as of Q1 2020
255 filings reported holding MED - MEDIFAST INC - Common Stock, $0.001 par value per share as of Q1 2020.
MEDIFAST INC - Common Stock, $0.001 par value per share (MED) has 183 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 12.4M shares
.
Largest 10 shareholders include BlackRock Inc. (1.65M shares), VANGUARD GROUP INC (1.28M shares), Engaged Capital LLC (1.16M shares), RENAISSANCE TECHNOLOGIES LLC (894K shares), MILLER VALUE PARTNERS, LLC (712K shares), CREDIT SUISSE AG/ (550K shares), DIMENSIONAL FUND ADVISORS LP (497K shares), RICE HALL JAMES & ASSOCIATES, LLC (421K shares), STATE STREET CORP (349K shares), and Nantahala Capital Management, LLC (273K shares).
This table shows the top 183 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.